Related Experiment Videos
A pilot study with monosialoganglioside GM1 on acute cerebral ischemia
Acta Neurologica
|June 1, 1990
Abstract:
Reported here are the results of an open controlled study on the use of GM1 in cases of ischemic strokes in its acute phase. A statistically significant improvement was observed in cases treated with GM1 for neurological deficits (assessed by Mathew's rating scale, modified by Fritz-Werner) at 21, 60 and 120 days and for disability at 120 days.